All In MedTech

FDA Clearance Tracker · P120020

SUPERA PERIPHERAL STENT SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Mar 28, 2014 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P120020
Device name
SUPERA PERIPHERAL STENT SYSTEM
Applicant location
Santa Clara, CA
Received
Nov 16, 2012
Decided
Mar 28, 2014
Decision
Approved
Supplements
37 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NIP

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE SUPERA® PERIPHERAL STENT SYSTEM. THIS DEVICE IS INDICATED TO IMPROVE LUMINAL DIAMETER IN THE TREATMENT OF PATIENTS WITH SYMPTOMATIC DE NOVO OR RESTENOTIC NATIVE LESIONS OR OCCLUSIONS OF THE SUPERFICIAL FEMORAL ARTERY (SFA) AND/OR PROXIMAL POPLITEAL ARTERY, WITH REFERENCE VESSEL DIAMETERS OF 4.0 TO 6.5 MM, AND LESION LENGTHS UP TO 140 MM.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NIP. The earliest in FDA's data is P000033, decided Apr 3, 2002.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Abbott Vascular (Idef Technologies Inc)

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.